| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 56 |
| 1 | PREDNISONE | 20 |
| 2 | INTERFERON BETA-1A | 17 |
| 3 | DIPHENHYDRAMINE HYDROCHLORIDE | 16 |
| 4 | ETANERCEPT | 16 |
| 5 | METHOTREXATE SODIUM | 16 |
| 6 | METHOTREXATE | 15 |
| 7 | NATALIZUMAB | 15 |
| 8 | ACETAMINOPHEN | 14 |
| 9 | METHYLPREDNISOLONE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEOXYCHOLIC ACID | 7 | 0.0030 |
| 1 | ADALIMUMAB-AFZB | 4 | 0.0015 |
| 2 | ANAGRELIDE HYDROCHLORIDE | 1 | 0.0009 |
| 3 | MITAPIVAT | 1 | 0.0008 |
| 4 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| 5 | GINKGO BILOBA | 1 | 0.0007 |
| 6 | DICLOFENAC SODIUM AND MISOPROSTOL | 4 | 0.0006 |
| 7 | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | 1 | 0.0006 |
| 8 | MIRVETUXIMAB SORAVTANSINE | 1 | 0.0006 |
| 9 | ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 24 |
| 1 | GLP-1 Receptor Agonist [EPC] | 22 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 22 |
| 3 | Interferon beta [EPC] | 18 |
| 4 | Integrin Receptor Antagonist [EPC] | 17 |
| 5 | Interleukin-23 Antagonist [EPC] | 17 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 17 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 16 |
| 8 | Benzodiazepine [EPC] | 12 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytolytic Agent [EPC] | 7 | 0.0030 |
| 1 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 2 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 3 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 4 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 5 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 3 | 0.0003 |
| 6 | Human Immunoglobulin G [EPC] | 6 | 0.0003 |
| 7 | Prostaglandin E1 Analog [EPC] | 4 | 0.0002 |
| 8 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 9 | Integrin Receptor Antagonist [EPC] | 17 | 0.0002 |